Our data strongly indicate that CXCR4 plays a significant role in the transformation of melanoma cells and suggest that targeting the CXCR4–RUNX2 axis and autophagy pathways may offer potential therapeutic avenues for counteracting melanoma bone metastasis. This evidence concerns the gene RUNX2 and melanoma.